Skip to main content

VTAMA cream can give plaque psoriasis patients significantly clearer skin.

So they’re free to think about… literally anything.

VTAMA® (tapinarof) cream, 1% is a first-in-class topical treatment for adults with plaque psoriasis. It’s an Aryl hydrocarbon Receptor (AhR) agonist that could change the approach to plaque psoriasis treatment.1,2

VTAMA cream
  • 6x the Efficacy vs Vehicle
    In two 12-week pivotal studies, the Physician Global Assessment (PGA) success* rate was 36% and 40% for patients using VTAMA cream vs 6% and 6% for patients on vehicle.1
  • Favorable Safety and Tolerability
    In clinical studies, VTAMA cream showed a favorable and consistent safety profile and was well tolerated, even on sensitive areas of skin.3,4
  • ~4 Month Off-Treatment Effect
    In an open-label, long-term extension study, the median time to first disease worsening (defined as PGA≥2 [mild]) was 114 days (n=73)(95% CI: 85, 142).1
*PGA success: PGA score of 0 or 1 and ≥2-grade improvement from baseline at week 12.
what patients from clinical studies
said about VTAMA cream
VTAMA® Cream and Droplet
~90% of patients said VTAMA cream is easy to apply, non-greasy, and absorbs quickly5
Checkmark next to VTAMA® Cream
84% of patients would recommend VTAMA cream to others if available5
Thumbs-up icon
83% of patients said they would use VTAMA cream again or continue to use treatment5
What would you like to see next?
Back to top